June 2018
Nizoral North America
Exclusive Financial Advisor to Johnson & Johnson on the Sale of the Rights of Nizoral in North America and Latin America to Kramer Laboratories, a Portfolio Company of Avista Capital
More Like This
-
US$2.7bPending Completion
MCR Investors
Financial Advisor to MCR Investors on its Significant Equity Investment in Conjunction with the Take-Private of Soho House
-
Ritter Sport
Exclusive Financial Advisor to Ritter Sport on its Acquisition of Chocolove
-
Designs for Health
Financial Advisor to Designs for Health on its Minority Investment from BDT & MSD Partners
